Suppr超能文献

对于有提示良性前列腺增生的下尿路症状(LUTS/BPH)的患者,从植物疗法改用坦索罗辛。

Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).

作者信息

Gross A J, Busse M, Leonard J, Schumacher H

机构信息

Marien Krankenhaus, Bergisch-Gladbach, Germany.

出版信息

Prostate Cancer Prostatic Dis. 2005;8(3):210-4. doi: 10.1038/sj.pcan.4500803.

Abstract

The aim of this observational prospective study was to evaluate the switch from phytotherapy to tamsulosin 0.4 mg once daily (o.d.) on efficacy, sexual function and tolerability in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) who have a poor response to at least 4 weeks of phytotherapy. The switch to tamsulosin 0.4 mg o.d. improves LUTS and related quality of life. Sexual function is also slightly improved. Tamsulosin is as well tolerated as phytotherapy and abnormal ejaculation appears to be no problem. Tamsulosin is perceived by both patients and urologists to be superior to preceding phytotherapy.

摘要

这项观察性前瞻性研究的目的是评估在接受至少4周植物疗法后反应不佳的下尿路症状/良性前列腺增生(LUTS/BPH)患者中,从植物疗法转换为每日一次服用0.4毫克坦索罗辛的疗效、性功能和耐受性。转换为每日一次服用0.4毫克坦索罗辛可改善LUTS及相关生活质量。性功能也略有改善。坦索罗辛的耐受性与植物疗法相当,异常射精似乎不是问题。患者和泌尿科医生都认为坦索罗辛优于之前的植物疗法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验